Insights Into Breast Cancer 2025 – California Summit

Comprehensive perspectives on current treatement practices for HR+ early breast cancer (eBC) and HR+ metastatic breast cancer (mBC), including expert analysis of therapeutic strategies, clinical decision-making, and reactions to recently introduced and emerging agents.

California Summit - October 25, 2025
Purchase Report

FACULTY CHAIR

Mark Pegram, MD

Stanford Women's Cancer Center, Palo Alto, CA, USA

Example Report

Start discovering the insights

View Report

MORE INFORMATION

  • Live summit
  • La Jolla, CA

REPORT SNAPSHOT

  • Assessed current treatment practices and recent updates in HR+ eBC and HR+ mBC, including the latest clinical data presented during the session
  • Investigated evolving management strategies and expert perspectives, informed by real-world feedback from participating oncologists
  • Interpreted key trends and discussion points shaping HR+ breast cancer

GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT

  • Data collection was accomplished using audience response system (ARS) questioning and moderated discussion
  • The experts included 13 community oncologists representing California and Nevada

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.